Article metrics

Download PDFPDF

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

 

Online download statistics by month:

Online download statistics by month: December 2019 to May 2022

AbstractFullPdf
Dec 201920200
Jan 202014214215
Feb 20201001003
Mar 202054544
Apr 2020646413
May 202010410410
Jun 2020545411
Jul 202036367
Aug 2020727275
Sep 2020777734
Oct 2020424132
Nov 2020777732
Dec 2020686838
Jan 2021767552
Feb 2021464637
Mar 202110510541
Apr 2021828241
May 2021797940
Jun 2021555524
Jul 2021525225
Aug 2021393923
Sep 2021555536
Oct 2021595958
Nov 2021535341
Dec 2021575736
Jan 2022526039
Feb 2022273130
Mar 2022485742
Apr 2022596346
May 2022414241
Total18951919926